Propionic Acid

Propionic Acid

SCHEMBL4158062

CCC(=O)O.CCOC(=O)c1ccc(NS(=O)(=O)c2ccc3[nH]c(=O)c4[nH]ccc4c3c2)cc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
ALDH1A1 P00352 3/20 0.60
HPGD P15428 2/20 0.60
ALOX15 P16050 1/20 0.60
MAPK1 P28482 1/20 0.60
HSD17B10 Q99714 1/20 0.60
LMNA P02545 7/20 0.59
MAPT P10636 6/20 0.59
TP53 P04637 3/20 0.59
SMN1; SMN2 Q16637 5/20 0.50
NHERF1 O14745 1/20 0.49
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
THRB P10828 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4157631 0.89 BRAF (0.54) MEN1KMT2AALDH1A1HPGDALOX15
Propionic Acid SCHEMBL4153953 0.87 PKM (0.55) MEN1KMT2AALDH1A1HPGDALOX15
Propionic Acid SCHEMBL4163285 0.87 PKM (0.54) LMNAMAPTTP53POLBTDP1
Propionic Acid SCHEMBL4163726 0.86 BRD4 (0.54) MEN1KMT2AALDH1A1HPGDMAPK1
Propionic Acid SCHEMBL4162959 0.86 BRAF (0.46) KMT2AALDH1A1LMNAMAPTTP53
Propionic Acid SCHEMBL4161141 0.86 BRAF (0.53) MEN1KMT2ALMNAMAPTTP53
Propionic Acid SCHEMBL4160232 0.86 BRD4 (0.51) LMNAMAPTTP53POLB
Propionic Acid SCHEMBL4162384 0.84 MAPT (0.49) MEN1KMT2AALDH1A1HPGDLMNA
Propionic Acid SCHEMBL4155591 0.83 BRD4 (0.50) MEN1KMT2AALDH1A1LMNAMAPT
Propionic Acid SCHEMBL4166797 0.83 PKM (0.43) MEN1KMT2AALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 MEN1 3749/4885KMT2A 1882/4885ALDH1A1 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.